Mode
Text Size
Log in / Sign up

Normal-tension glaucoma

Part of Glaucoma

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for normal-tension glaucoma

5 trials tracked for normal-tension glaucoma: 2 in phase 3 or 4.

5Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Other / NA 3
  1. Phase 4 Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Completed
  2. Phase 4 Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma Completed
  3. N/A Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma Completed
  4. N/A Systemic Glutathione Level in Normal Tension Glaucoma Completed
  5. N/A Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Glaucoma

Related studies from across the Glaucoma family.

Ocular morbidity prevalence of 43.1% among incarcerated populations in sub-Saharan Africa
Ophthalmology Meta-analysis
Ocular morbidity prevalence of 43.1% among incarcerated populations in sub-Saharan Africa Factors Linked to Eye Conditions in Sub-Saharan African Prisons
This meta-analysis of 3,361 individuals in sub-Saharan African prisons identifies a 43.1% prevalence of ocular morbidity. Key associated fac…
A study of over 3,000 people in African prisons found that age, past injuries, and length of stay are linked to common eye conditions.
Rheumatic diseases linked to 66% higher glaucoma risk in pooled analysis
Ophthalmology Meta-analysis
Rheumatic diseases linked to 66% higher glaucoma risk in pooled analysis Rheumatic Diseases Linked to Higher Risk of Glaucoma
This meta-analysis examined glaucoma incidence and risk in individuals with rheumatic diseases versus the general population. Pooled data sh…
People with rheumatic diseases may face a 66% higher risk of developing glaucoma compared to the general population.
Dysregulation of intraocular immune pathways plays a central role in progressive retinal ganglion cell death
Neurology Sys. Review
Dysregulation of intraocular immune pathways plays a central role in progressive retinal ganglion cell death Immune Pathways Play Central Role in Glaucoma Progression
This systematic review examines the role of intraocular immune pathways, including microglia, astrocytes, and T cells, in glaucoma progressi…
New research highlights how immune system issues inside the eye may contribute to the death of nerve cells in glaucoma patients.
Transconjunctival bleb needling with mitomycin C reduces intraocular pressure in pediatric congenital glaucoma
Ophthalmology Sys. Review
Transconjunctival bleb needling with mitomycin C reduces intraocular pressure in pediatric congenital glaucoma New surgical technique helps manage severe glaucoma in children
This case report describes a 9-year-old patient with refractory primary congenital glaucoma. Transconjunctival bleb needling with mitomycin …
A minimally invasive procedure helped lower high eye pressure in a child with severe glaucoma and a complex surgical history.
Intraluminal stent removal from Paul glaucoma implants significantly reduces intraocular pressure in glaucoma patients
Ophthalmology Meta-analysis
Intraluminal stent removal from Paul glaucoma implants significantly reduces intraocular pressure in glaucoma patients Stent Removal Reduces Eye Pressure in Glaucoma Patients
This meta-analysis of 5 observational studies indicates that removing the intraluminal stent from a Paul glaucoma implant (PGI) significantl…
Removing a specific internal stent from a glaucoma implant can significantly lower eye pressure, especially for patients with high initial p…
Medicinal mushroom-derived compounds show potential for managing oxidative stress and inflammation in ocular conditions
Drug Pipeline Sys. Review
Medicinal mushroom-derived compounds show potential for managing oxidative stress and inflammation in ocular conditions Medicinal mushrooms show promise for several common eye conditions
This narrative review synthesizes evidence regarding medicinal mushroom-derived bioactive compounds, including polysaccharides and triterpen…
Medicinal mushrooms contain compounds that may protect the eyes from inflammation and damage, though more clinical trials are needed to conf…
Oxidative stress and reactive oxygen species mediate retinal ganglion cell death and optic nerve damage
Drug Pipeline Sys. Review
Oxidative stress and reactive oxygen species mediate retinal ganglion cell death and optic nerve damage Oxidative stress and nerve damage drive glaucoma progression
This narrative review explores the role of oxidative stress and reactive oxygen species (ROS) as key mediators of retinal ganglion cell deat…
New research identifies how oxidative stress and reactive oxygen species damage the optic nerve in people with glaucoma.
Postoperative glaucoma occurs in 25.6% of eyes following Boston Type 1 Keratoprosthesis implantation
Ophthalmology Meta-analysis
Postoperative glaucoma occurs in 25.6% of eyes following Boston Type 1 Keratoprosthesis implantation Meta-analysis tracks glaucoma risks after Boston Type 1 Keratoprosthesis
This meta-analysis of 1,482 eyes evaluates glaucoma outcomes following Boston Type 1 Keratoprosthesis (KPro) implantation. The study reports…
A meta-analysis of 1,482 eyes shows that about 25.6% of patients experience some form of glaucoma after a Boston Type 1 Keratoprosthesis pro…
Preservative Free Bimatoprost 0.01% Shows Non Inferiority to Higher Concentration Formulations
Ophthalmology Sys. Review
Preservative Free Bimatoprost 0.01% Shows Non Inferiority to Higher Concentration Formulations Preservative-free bimatoprost shows similar results for glaucoma eye pressure
Preservative-free bimatoprost 0.01% provides comparable intraocular pressure reduction to higher concentrations with improved local tolerabi…
A new look at eye drops shows that preservative-free bimatoprost lowers eye pressure as well as stronger versions with fewer side effects.
Photobiomodulation protocol aims to consolidate preclinical evidence for ophthalmic diseases
Rheumatology Meta-analysis
Photobiomodulation protocol aims to consolidate preclinical evidence for ophthalmic diseases Planning to Review Light Therapy for Common Eye Diseases and Injuries
This is a protocol for a systematic review and meta-analysis, not a completed study. It outlines plans to evaluate photobiomodulation (PBM) …
Experts are planning a large review to see if light therapy can help treat common eye problems like glaucoma and vision loss.
Portable visual-field testing devices show 86% sensitivity and 88% specificity for glaucoma diagnosis
Ophthalmology Meta-analysis
Portable visual-field testing devices show 86% sensitivity and 88% specificity for glaucoma diagnosis Portable devices show promise for diagnosing glaucoma more quickly
This meta-analysis of 2,254 participants with glaucoma and controls evaluated the diagnostic accuracy of portable visual-field testing devic…
New research suggests portable vision tests can accurately detect glaucoma while significantly cutting down the time patients spend in testi…
Glucocorticoid signaling and stress-related neuroendocrine dysregulation influence intraocular pressure and inflammatory pathways in ocular diseases
Rheumatology Sys. Review
Glucocorticoid signaling and stress-related neuroendocrine dysregulation influence intraocular pressure and inflammatory pathways in ocular diseases Stress and hormones may play a role in eye health
This narrative literature overview of 35 studies synthesizes the role of glucocorticoid signaling and stress-related neuroendocrine dysregul…
New research suggests that stress-related hormone changes could influence conditions like glaucoma and other serious eye diseases.